Related Experiment Video

Updated: Aug 5, 2025

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.9K

Host Cell Targets for Unconventional Antivirals against RNA Viruses

Vicky C Roa-Linares1, Manuela Escudero-Flórez1, Miguel Vicente-Manzanares2

  • 1Molecular and Translation Medicine Group, University of Antioquia, Medellin 050010, Colombia.

Viruses
|March 30, 2023
PubMed

Insights

RNA viruses like SARS-CoV-2 mutate rapidly, challenging treatments. Targeting host cell factors offers a broad-spectrum antiviral strategy, with ferruginol analogs showing promise.

Area of Science:

  • Virology
  • Drug Discovery
  • Molecular Biology

Background:

  • RNA viruses, including SARS-CoV-2, HIV, and influenza, possess high mutation rates due to error-prone RNA-dependent RNA polymerases.
  • This high mutation frequency complicates the development of effective vaccines and antiviral therapies, often leading to drug resistance.

Purpose of the Study:

  • To review small molecules targeting host cell factors for broad-spectrum antiviral activity against RNA viruses.
  • To highlight the potential of repurposing FDA-approved drugs and explore novel compounds like ferruginol analogs.

Main Methods:

  • Literature review of antiviral strategies targeting host cell machinery.
  • Analysis of small molecules with demonstrated efficacy against various RNA viruses.
  • Focus on host-targeted therapies as an alternative to direct antiviral agents.

Main Results:

  • Host cell machinery is crucial for RNA virus replication, making it a viable therapeutic target.
  • Repurposed FDA-approved drugs exhibit broad-spectrum antiviral potential.
  • Ferruginol analog (18-(phthalimide-2-yl) ferruginol) identified as a promising host-targeted antiviral candidate.

Conclusions:

  • Targeting host factors presents a viable strategy to combat RNA virus infections and overcome drug resistance.
  • Further investigation into ferruginol analogs is warranted for developing novel antiviral treatments.
Keywords:
RNA virusesdrug repositioninghost-targeted antivirals

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

7.9K
Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery13:47

Development of Cell-type specific anti-HIV gp120 aptamers for siRNA delivery

Published on: June 23, 2011

19.6K

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
62
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.4K
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.6K
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
56
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.2K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
76